![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by Staff Writers Beijing (AFP) July 18, 2020
China launched mass health screenings in Xinjiang on Saturday after a spike in coronavirus cases raised fears of a fresh outbreak in the far western province. The new cases illustrate the continuing difficulty China faces in stamping out the contagion, which emerged in the central Chinese city of Wuhan late last year before spreading around the world. The new testing regime comes a day after authorities curtailed most flights into regional capital Urumqi and shut down local subway and public transport services. The city had recorded 17 new coronavirus infections as of Saturday, authorities said in a briefing. Mass screening for the virus will begin in buildings which had reported new cases and eventually cover all of Urumqi, said local health commission chief Zhang Wei. "The whole city has entered a 'wartime state', and will suspend all kinds of group activities," an official said at the briefing, according to state media reports. Urumqi residents were also urged not to leave the city unless absolutely necessary. Strict lockdowns across the country and widespread COVID-19 testing largely brought the outbreak under control within Chinese borders earlier this year. But a new cluster emerged in Beijing in June and infecting more than 330 people before it was contained, after millions of people living in the capital were tested for transmission. Xinjiang was one of the first regions to let students return to school in late March after authorities declared an end to the initial wave of the COVID-19 outbreak. Ethnic Uighurs and other Turkic Muslims make up around half of the remote and landlocked region's population. Many of them complain of decades of political and religious oppression by China's ruling Communist Party, which the government denies.
![]() ![]() Millions face new virus curbs, but hope rises for US vaccine Hong Kong (AFP) July 15, 2020 Millions of people faced new coronavirus restrictions on Wednesday as infections surge, but in one sign of hope, an American firm said it would soon start final-stage human trials for a possible vaccine. Countries around the world re-imposed lockdowns and curbs to contain new outbreaks, as global cases surged past 13.2 million with more than 576,000 deaths. Parts of the Asia-Pacific region, which had been somewhat successful in fighting the pandemic, provided fresh evidence of the deadly threat ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |